克雅病试用喹纳克林未显示显著效果
Compassionate use of quinacrine in Creutz- feldt-Jakob disease fails to show significant effects作者机构:Raymond Escourolle Neuropathol. Lab. INSERM U360 Salpêtrière Hospital 47 bd de l'Hpital 75651 Paris Cedex 13 France Dr.
出 版 物:《世界核心医学期刊文摘(神经病学分册)》 (Digest of the World Core Medical Journals:Clinical Neurology)
年 卷 期:2005年第1卷第5期
页 面:46-46页
学科分类:1002[医学-临床医学] 100204[医学-神经病学] 10[医学]
摘 要:Quinacrine has been reported as an antiprion agent and proposed as an immedia tely applicable treatment for Creutzfeldt-Jakob disease (CJD). The authors rep ort the results of an open compassionate procedure to which 32 CJD patients had access. In some genotypic subgroups, a slight but nonsignificant increase in sur vival was observed, likely due to biased inclusion of longterm surviving patient s. There was no pathologic evidence of a beneficial effect of quinacrine treatme nt.